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ABSTRACT: Fe is essential for human life because it constitutes the required cofactor for proteins of diverse biological 
functions. However, the development of oxidative stress by exposure to excessive Fe, share signaling pathways with 
other treatments including activation of redox-sensitive factors. This study was focused on the comparison on the 
effects of Fe in the brain and other organs in vivo. The oxidative effects triggered by Fe overload strongly depend 
not only on the administration protocol, but also on the Fe-compound used, and the studied organ. In both the liver 
and the brain, Fe content drastically increased after Fe-dextran administration. However, the comparatively low 
lipid peroxidation in the brain as compared to the liver, suggested that Fe-dependent oxidative stress might involve 
mechanisms of different nature. In the brain, acute and subchronic administration of Fe-dextran triggered signaling 
processes that lead to the prevention of injury by the participation of catalase activity as an antioxidant protection. 
This brief summary opens a huge range of possible points of risk, as well as opportunities, to encounter situations 
in which the appropriate election of the Fe management protocol could be able of allow oxidative stress to exert 
beneficial effects.
Fe is essential for life because it constitutes the required 
cofactor for a multitude of proteins of diverse biological 
functions. The one-electron interconversion between Fe(II) 
and Fe(III), which makes Fe the key factor for biological 
redox processes, is also the process by which Fe becomes 
toxic through the generation of O2-derived radicals and other 
damaging species. The development of oxidative stress by 
exposure to excessive Fe, shares signaling pathways with other 
treatments including activation of redox-sensitive factors. 
However, the nature of the model used for Fe administration 
seems as a key issue. The analysis presented here, studying 
the Fe-related changes by the generation of oxidative stress 
using resonance electron spectroscopy techniques (EPR), 
antioxidant capacity by HPLC and biochemical tools, was 
focused on the comparison on Fe effects in the brain and 
other organs in vivo. The possible role of hormesis, i.e., the 
induction of protective mechanisms by moderate conditions 
of oxidative stress previous to a challenge, will be discussed. 
Fe overload in humans has been observed when dietary 
Fe is excessive, such as in the severe siderosis in Bantu 
people who drink acidic beer out of Fe pots, or in excessive 
Fe treatment of anemias (Puntarulo and Galleano, 2009). 
Also, Fe overload is found in inherited diseases, such as 
congenital atransferrinemia (lack of circulating transferrin) 
or during the medical treatment of thalassemia (a genetic 
disorder in which the rate of synthesis of one or more of 
the hemoglobin chains is diminished; Puntarulo, 2005). 
To characterize these conditions, several models of Fe-
administration in rats were used. Experimental Fe overload 
using dietary supplementation with carbonyl-Fe in the rat 
is a well-established model, where Fe deposition occurs 
mainly in periportal hepatocytes, in a distribution as it 
was observed in idiopathic hemochromatosis (Powell et al., 
1980). Moreover, it has been reported that dietary Fe overload 
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led to an increase in lipid oxidation (Dabbagh et al., 1994); 
however, Bacon et al. (1989) concluded that Fe-induced 
peroxidative damage to hepatic membrane lipids in chronic 
Fe overload depended on the hepatic Fe concentration. In 
our model, a carbonyl-Fe (2.5% w/v) diet was used for 6 
weeks. The treatment led to a drastic increase (from 69±16 
to 1091±178 µg Fe/g fresh tissue weight, (µg/g FW) after 6 
weeks of administration in the Fe content in the liver and 
plasma, respectively; with a slight increase in the content of 
thiobarbituric acid reactive substances (TBARS, used as an 
index of lipid peroxidation; Galleano and Puntarulo, 1997). 
The significant increase in Fe content suggested a pattern of 
incorporation of Fe in a gradual manner that facilitates the 
incorporation of Fe in deposit molecules (i.e., ferritin) that 
would be effective in preventing oxidative damage (Galleano 
and Puntarulo, 1997).
Treatment of rats with Fe-dextran resembles hemo-
chromatosis secondary to Fe-loading (anemias treated with 
repeated transfusions) and high Fe oral intake (Powell et al., 
1980). It has been suggested that increased intracellular Fe 
may initiate several hepatotoxic processes (Bacon and Brit-
ton, 1989); however, there were no confirmatory studies of 
the presence of an expanded intracellular Fe pool (Galleano 
and Puntarulo, 1992). Acute Fe overload employing Fe-dex-
tran (500 mg /kg) was studied in liver (Galleano and Pun-
tarulo, 1992), kidney (Galleano and Puntarulo, 1994), plas-
ma (Galleano and Puntarulo, 1995) and brain (Piloni et al., 
2013). Table 1 shows Fe distribution in control and overload 
conditions, expressed both as the concentration per gram of 
dry tissue weight (µg/g DW), fresh tissue weight (µg/g FW) 
and as % of the concentration in fresh liver tissue. Both the 
DW and FW concentrations increased drastically after Fe 
overload, but the % distribution was essentially the same 
as in controls. Thus, the protection afforded by the blood-
brain barrier would not avoid the adverse Fe excessive entry. 
Moreover, the drastic Fe increase seen in brain strongly sug-
gested that brain could be a target organ for Fe-dependent 
oxidative damage. After acute treatment, an increase in the 
total Fe content was also measured in the isolated brain re-
gions (cortex, hippocampus, striatum) (Piloni and Puntaru-
lo, 2014), 6 h after Fe-dextran treatment.
Even though lipid peroxidation is thought a key factor 
for the deleterious effects of Fe in biological systems (Lu and 
Koppenol, 2005), TBARS content was not equally affected 
by acute Fe-dextran treatment in all of the studied organs. 
TBARS generation rate in liver of Fe-dextran treated rats was 
increased by 175% (Galleano and Puntarulo, 1992) and by 
27% in kidney (Galleano et al.,1994), and TBARS content 
was unchanged in brain (Piloni et al., 2013) and increased by 
285% in plasma (Galleano and Puntarulo, 1995). These re-
sults suggested that the different antioxidant system profiles 
may be responsible for controlling lipid deterioration in the 
different organs.
The massive change in brain Fe content led to an 
increase in the oxidative stress index in the hydrophilic 
medium, the ascorbyl radical content (A•)/ascorbate content 
(AH-) ratio, by 55%, and the activity of the enzyme catalase 
(CAT) enhanced in the areas studied at 6 h post-treatment 
(Piloni and Puntarulo, 2014). Also, the content of glutathione 
(GSH) decreased after 6 h and 8 h post-injection in cortex, 
hippocampus and was unchanged in striatum (Reiteri et al., 
2014). These results suggested that the antioxidant response 
is not uniform in all brain areas, because certain areas seem 
less likely to express oxidative damage than others do. Piloni 
TABLE 1
Effect of acute Fe-dextran administration on Fe content in several rat organs
Fe content
Organ Control + Fe-dextran
μg/g FW % μg/g FW %
Liver 1257±11 μg/g DW 77±4 100 11837±205 μg/g DW 552±62 100
Kidney 214±3 μmoles/g DW 156±33 203 2113±15 μmol/g DW 1260±167  228
Plasma 3126±20 μg/dl 1.3±0.2 1.6 31538±158 μg/dl 15±2 2.8
Brain 4635±187 pmol/mg FW 35±10  45 45403±1551 pmol/mg FW 301±87 55
1 Galleano and Puntarulo, 1992; 2Galleano et al., 1994; 3Galleano and Puntarulo, 1995;4Piloni et al., 2013
Plasma density was considered as 1 g/ml, kidney water content as 80%. Fe content in Fe-dextran treated 
animals was measured after 6 h of treatment in liver and brain, and after 20 h of treatment in kidney and 
plasma.
DW indicates dry tissue weight, and FW indicates fresh tissue weight.
41FE OXIDATIVE METABOLISM
et al. (2013) reported that increased Fe in the acute overload 
condition was related to an increase in the binding capacity 
of factor NF-ΚB to DNA, and to a significant increase in the 
activity of the antioxidant enzyme CAT.
For a subchronic treatment, the rats were injected in-
traperitoneally (ip) with Fe-dextran (50 mg/kg every 48 h, 6 
injections). This treatment changed Fe content from 3.3±0.3 
to 75±7 μg/g FW in the liver (Tapia et al., 1998) and from 
47±1 to 360±14 μg/g FW in the brain (Piloni et al., under 
consideration). The total Fe content in the whole brain and 
in the cortex, hippocampus and striatum was increased at 2 
h post-administration of the 6th dose. The generation rate of 
RL• and the A•/AH- ratio, 2 h post-treatment, increased by 
97% and 3.9-fold, respectively. CAT activity increased in the 
cortex at 2, 4, 6, and 8 h post-treatment (Reiteri et al., 2014). 
The data suggested that after both Fe-dextran protocols 
(acute and subchronic), the brain protection mechanisms 
that were triggered were based on CAT activity.
Due to this close association between oxidative stress 
and Fe, the effect of the establishment of an oxidative 
condition and the alteration of Fe oxidative metabolism 
at the cellular level was considered. Robello et al. (2012) 
reported that fetal brain cells in culture (obtained from rats 
γ-irradiated in utero, a well-known trigger for oxidative 
stress), the content of total Fe and the level of lipid 
peroxidation were increased 4 h post-treatment. However, 
the direct irradiation of cells in vitro did not generate any 
changes in the fetal brain total Fe content, even though 
the A•/AH- ratio was significantly increased (Robello et al., 
2012). Thus, these authors postulated that in vivo irradiation 
affected the oxidative metabolism of Fe in the fetal brain 
mainly by Fe leak from maternal membranes damaged 
by radiation-dependent processes. The excess Fe coming 
from the injured membranes could be routed to fetal brain 
tissues through maternal blood circulation (Robello and 
Puntarulo, 2014), which indicates the need to be cautious 
when postulating direct mechanistic links between different 
oxidative conditions and Fe alterations. 
Even more, in some cases, the displacement of Fe from 
membranes by in vivo treatment with toxic compounds 
(such as As-compounds), was postulated as a contributing 
factor to lipid peroxidation of brain membranes, probably 
by removing Fe from ferritin (Ahmad et al., 2000). Bonetto 
et al. (2014) and Piloni et al. (2014) reported an increase 
in the As content in blood and brain of rats, 8 h after i.p. 
administration of 5.8 mg As/kg (as sodium arsenite). 
Neither the A•/AH- ratio nor the generation rate of the 
hydroxyl radical (•OH) were significantly different between 
treated and control brains. However, the rate of generation 
of the RL• was significantly increased in brain from animals 
receiving As (Bonetto et al., 2013). 
From an integrative view of the experimental evidence, 
the following conclusions would be suggested: (1) the 
oxidative effects triggered by Fe overload strongly depend 
not only on the way of administration, but also on the Fe-
compound used (carbonyl-Fe, dextran-Fe) and the studied 
organ (liver, kidney, plasma or brain); (2) in the liver and 
the brain, Fe content drastically increased after Fe-dextran 
administration; however, the comparatively low lipid 
peroxidation in the brain as compared to the liver suggested 
that Fe-dependent oxidative stress could involve different 
mechanisms in those tissues; and (3) in the brain, both 
acute and subchronic administration of Fe-dextran, may 
be triggering signaling processes leading to prevention of 
injury, with the participation of CAT activity. This hormetic 
effect should be considered for the development of possible 
medical-therapeutic uses. 
This view opens a range of possible risks and opportu-
nities, because the appropriate selection of a Fe management 
protocol may allow oxidative stress to exert beneficial effects 
that could be applied to the treatment of critical conditions 
such as neurodegenerative diseases.
References
Ahmad S, Kitchin K T, Cullen WR (2000). Arsenic species that cause re-
lease of iron from ferritin and generation of activated oxygen. Ar-
chives of Biochemistry and Biophysics 382: 195-202
Bacon BR, Britton RS (1989). Hepatic injury in chronic iron overload: role 
of lipid peroxidation. Chemico-Biological Interactions 70: 183-226.
Bacon BR, Britton RS, O’Neill R (1989). Effects of vitamin E deficiency on 
hepatic mitochondrial lipid peroxidation and oxidative metabolism 
in rats with chronic dietary iron overload. Hepatology 9: 398-404.
Bonetto J, Villamil E, Puntarulo S (2014). Update on the oxidative stress asso-
ciated with arsenic exposure. Current Topics in Toxicology 10: 37-48.
Bonetto JG, Robello E, Villaamil E, Puntarulo S (2013). Estrés oxidativo en 
la fase lipofílica asociada a la suplementación con As en el cerebro. 
Medicina Buenos Aires 73 (III): 299.
Dabbagh A J, Mannion T, Lynch SM, Frei B (1994). The effect of iron 
overload on rat plasma and liver oxidant status in vivo. Biochemical 
Journal 300: 799-803.
Lu C, Koppenol WH (2005). Inhibition of the Fenton reaction by nitrogen 
monoxide. Journal of Biological Inorganic Chemistry 10: 732-738.
Galleano M, Puntarulo S (1997). Dietary α-tocopherol supplementation on 
antioxidant defenses after in vivo iron overload in rats. Toxicology 
124: 73-81.
Galleano M, Farré S, Turrens JF, Puntarulo S (1994). Resistance of rat kid-
ney mitochondrial membranes to oxidation induced in acute iron 
overload. Toxicology 88: 141-149.
Galleano M, Puntarulo S (1992). Hepatic chemiluminescence and lipid 
peroxidation in mild iron overload. Toxicology 76: 27-38. 
Galleano M, Puntarulo S (1994). Effect of mild iron overload on liver and 
kidney lipid peroxidation. Brazilian Journal of Medical Biological 
Research 27: 2349-2358. 
Galleano M, Puntarulo S (1995). Role of antioxidants on the erythrocytes 
resistance to lipid peroxidation after acute iron overload in rats. 
Biochemical and Biophysical Acta 1271: 321-326.
42
Piloni N, Robello E, Bonetto J, Reiteri M, Fagali N, Puntarulo S (2014). 
Metabolismo oxidativo dependiente de Fe: un enfoque integral. 
Avances y perspectivas de los estudios realizados en el Instituto de 
Bioquímica y Medicina Molecular (IBIMOL). I Encuentro IBIMOL, 
Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, 
page 5 http://www.ffyb.uba.ar/ibimol/publicacion-encuentros-ibi-
mol?es,,mnu-e-54-13-mnu-
Piloni NE, Fermandez V, Videla LA, Puntarulo S (2013). Acute iron over-
load and oxidative stress in brain. Toxicology 314: 174-182.
Piloni NE, Puntarulo (2014). Estrés oxidativo en cerebro de ratas someti-
das a sobrecarga aguda y subcrónica de Fe. I Encuentro Instituto de 
Bioquímica y Medicina Molecular (IBIMOL). Facultad de Farmacia 
y Bioquímica, Universidad de Buenos Aires. http://www.ffyb.uba.
ar/ibimol/ii-encuentro-2014?es
Powell LW, Bassett ML, Halliday JW. (1980). Hemochromatosis: 1980 up-
date. Gastroenterology 78: 374-381.
Puntarulo S (2005). Iron, Oxidative Stress and Human Health. Molecular 
Aspects of Medicine 26: 299-312.
Puntarulo S, Galleano M (2009). Forms of iron binding in the cells and the 
chemical features of chelation therapy. Mini-Reviews in Medicinal 
Chemistry 9: 1136-1146.
Reiteri M, Piloni NE, Hernando M, Cervino C, Puntarulo S (2014). 
Sobrecarga aguda de Fe: Efecto sobre la capacidad antioxidante 
no-enzimática en áreas cerebrales de rata. I Encuentro Instituto de 
Bioquímica y Medicina Molecular (IBIMOL). Facultad de Farmacia 
y Bioquímica, Universidad de Buenos Aires. http://www.ffyb.uba.
ar/ibimol/ii-encuentro-2014?es
Robello E, Piloni N, Puntarulo S (2012). γ-Irradiation effect on Fe content in 
developing neural precursor cells requires mother-fetus interaction. 
Current Topics in Toxicology 8: 83-93.
Robello E, Puntarulo S (2014). Metabolismo oxidativo del Fe en cerebro 
en desarrollo expuesto a la radiación-gama. I Encuentro Instituto de 
Bioquímica y Medicina Molecular (IBIMOL). Facultad de Farmacia 
y Bioquímica, Universidad de Buenos Aires. http://www.ffyb.uba.
ar/ibimol/ii-encuentro-2014?es
Tapia G, Troncoso P, Galleano M, Fernandez V, Puntarulo S, Videla LA 
(1998). Time course study of the influence of acute iron overload on 
Kupffer cell functioning and hepatotoxicity assessed in the isolated 
perfused rat liver. Hepatology 27: 1311-1316.
NATACHA E PILONI et al.
